The U.S. Senate on Dec. 16 passed the FDA Modernization Act 3.0 (S.355) by unanimous consent, sending legislation to the House that would require the FDA to update its regulations to reflect changes Congress enacted in 2022. The bill instructs HHS, acting through the FDA commissioner, to publish...
Bobbi Harris leads the Utility Broadband Alliance, also known as UBBA, which connects over 115 companies to address utility broadband infrastructure challenges.
Continue reading →
An October bump in orders for freight trailers proved short-lived rather than the start of a sustained recovery, as November numbers for U.S. trailer net orders dropped 19% month-over-month (m/m) to 13,071 units and an even bigger 45% drop year-over-year (y/y), according to transportation sector...
Warehouse management system (WMS) software vendor Softeon will be acquired by the Swedish enterprise resource planning (ERP) software vendor IFS in a move that IFS said would create an integrated platform that connects manufacturing operations seamlessly with intelligent warehouse execution.IFS...
This week’s ThreatsDay Bulletin tracks how attackers keep reshaping old tools and finding new angles in familiar systems. Small changes in tactics are stacking up fast, and each one hints at where the next big breach could come from. From shifting infrastructures to clever social hooks, the...
Threat actors with ties to the Democratic People’s Republic of Korea (DPRK or North Korea) have been instrumental in driving a surge in global cryptocurrency theft in 2025, accounting for at least $2.02 billion out of more than $3.4 billion stolen from January through early December. The...
Hewlett Packard Enterprise (HPE) has resolved a maximum-severity security flaw in OneView Software that, if successfully exploited, could result in remote code execution. The critical vulnerability, assigned the CVE identifier CVE-2025-37164, carries a CVSS score of 10.0. HPE OneView is an IT...
Thursday 29 January 2026 07:00 10:00 15:00 In this webinar, presented in association with the journal mAbs, Drs. Crescioli and Reichert discuss recent trends in antibody therapeutics development and forecast key events that may occur in 2026. They will begin with a brief review of approvals...